La Jolla Pharmaceutical Co.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 4,362 1,353 177 13
Sales, General and Admin. 13,577 9,386 2,097 3,915
Non-Recurring Items - - - -
Other - - - -
Operating Income (17,939) (10,739) (2,274) (3,928)
Income From Continuing Operations
Add'l Income/Expense Items 4 3,002 (9,274) 168
Earnings Before Interest and Tax (17,935) (7,737) (11,548) (3,760)
Interest Expense - - - -
Earnings Before Tax (17,935) (7,737) (11,548) (3,760)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (17,935) (7,737) (11,548) (3,760)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (17,935) (7,737) (11,548) (3,760)
Preferred Stock and Other Adjustments (801) (780) (119) (466)
Net Income Applicable to Common Shareholders (18,736) (8,517) (11,667) (4,226)